Alimentary Pharmacology & Therapeutics

© 2013 Blackwell Publishing Ltd

Cover image for Vol. 36 Issue 5

September 2012

Volume 36, Issue 5

Pages 405–501

  1. SYSTEMATIC REVIEW

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Systematic review: hypomagnesaemia induced by proton pump inhibition (pages 405–413)

      M. W. Hess, J. G. J. Hoenderop, R. J. M. Bindels and J. P. H. Drenth

      Article first published online: 4 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05201.x

      Corrected by:

      Corrigenda: Corrigenda

      Vol. 36, Issue 11-12, 1109, Article first published online: 7 NOV 2012

  2. META-ANALYSIS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection (pages 414–425)

      A. G. McNicholl, P. M. Linares, O. P. Nyssen, X. Calvet and J. P. Gisbert

      Article first published online: 15 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05211.x

  3. RANDOMISED CLINICAL TRIALS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have full text access to this OnlineOpen article
      Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study (pages 426–436)

      V. Thorat, N. Reddy, S. Bhatia, A. Bapaye, J. S. Rajkumar, D. D. Kini, M. M. Kalla and H. Ramesh

      Article first published online: 4 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05202.x

    2. You have full text access to this OnlineOpen article
      Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS (pages 437–448)

      F. Cremonini, J. P. Nicandro, V. Atkinson, R. Shringarpure, E. Chuang and A. Lembo

      Article first published online: 10 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05208.x

  4. INFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism (pages 449–458)

      D. Q. Shih, M. Nguyen, L. Zheng, P. Ibanez, L. Mei, L. Y. Kwan, K. Bradford, C. Ting, S. R. Targan and E. A. Vasiliauskas

      Article first published online: 11 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05206.x

    2. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease (pages 459–466)

      P. S. A. de Silva, D. D. Nguyen, J. Sauk, J. Korzenik, V. Yajnik and A. N. Ananthakrishnan

      Article first published online: 11 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05214.x

  5. PYOGENIC LIVER ABSCESS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study (pages 467–476)

      W.-Y. Kao, C.-Y. Hwang, Y.-T. Chang, C.-W. Su, M.-C. Hou, H.-C. Lin, F.-Y. Lee, S.-D. Lee and J.-C. Wu

      Article first published online: 10 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05212.x

  6. UPPER GASTROINTESTINAL BLEEDING

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study (pages 477–484)

      N. L. de Groot, J. H. Bosman, P. D. Siersema, M. G. H. van Oijen and A. J. Bredenoord, on behalf of the RASTA study group

      Article first published online: 2 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05205.x

  7. NSAID–ASSOCIATED ANAEMIA

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) (pages 485–492)

      A. Lanas, J. L. Goldstein, F. K. L. Chan, C. M. Wilcox, D. A. Peura, C. Li, G. H. Sands and J. M. Scheiman

      Article first published online: 15 JUL 2012 | DOI: 10.1111/j.1365-2036.2012.05213.x

  8. INVITED COMMENTARIES

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Commentary: simvastatin as the key to improving H. pylori eradication rates? (page 493)

      W. J. den Hollander and E. J. Kuipers

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05195.x

    2. You have free access to this content
      Commentary: simvastatin as the key to improving H. pylori eradication rates? Authors’ reply (page 494)

      W. Nseir and J. Mograbi

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05216.x

    3. You have free access to this content
      Commentary: endoscopic dilatation for stricturing Crohn's disease (pages 494–496)

      E. Louis, P. Gast, C. Van Kemseke and C. Reenaers

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05209.x

  9. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIALS
    5. INFLAMMATORY BOWEL DISEASE
    6. PYOGENIC LIVER ABSCESS
    7. UPPER GASTROINTESTINAL BLEEDING
    8. NSAID–ASSOCIATED ANAEMIA
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Letter: anti-TNFs and psoriasis – friends or foes? (page 497)

      I. Guerra and J. P. Gisbert

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05136.x

    2. You have free access to this content
      Letter: anti-TNFs and psoriasis – friends or foes? Authors’ reply (page 498)

      A. Buisson and L. Peyrin-Biroulet

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05222.x

    3. You have free access to this content
      Letter: infliximab and adalimumab in the management of Crohn's disease – are they really comparable? (pages 498–499)

      A. Lopez-Sanroman and J. P. Gisbert

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05185.x

    4. You have free access to this content
      Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD (pages 499–500)

      C. Steenholdt, J. Brynskov and K. Bendtzen

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05204.x

    5. You have free access to this content
      Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD – authors’ reply (page 501)

      S. Ben-Horin and Y. Chowers

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2036.2012.05215.x

SEARCH

SEARCH BY CITATION